National Health Investors, Inc. provided earnings guidance for the full year 2022. For the period, the company expected net income attributable to common stockholders to be in the range of $88.2 million to $90 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.89 USD | +0.31% | -1.05% | +19.77% |
26/06 | Truist Securities Adjusts Price Target on National Health Investors to $65 From $58, Maintains Hold Rating | MT |
29/05 | Declaration of Voting Results by National Health Investors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.77% | 289.56Cr | |
+12.93% | 6.03TCr | |
+0.02% | 2.02TCr | |
-2.17% | 1.35TCr | |
+9.07% | 821.6Cr | |
-5.17% | 619.3Cr | |
+10.10% | 356.21Cr | |
+3.85% | 343.77Cr | |
-11.55% | 290.09Cr | |
-5.30% | 282.65Cr |
- Stock Market
- Equities
- NHI Stock
- News National Health Investors, Inc.
- National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2022